Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition.
Biomolecules. 2020 Aug 18;10(8):1198. doi: 10.3390/biom10081198.
Biomolecules. 2020.
PMID: 32824740
Free PMC article.
Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
Aymerich MS, Rojo-Bustamante E, Molina C, Celorrio M, Sánchez-Arias JA, Franco R.
Aymerich MS, et al. Among authors: rojo bustamante e.
Mol Neurobiol. 2016 May;53(4):2312-9. doi: 10.1007/s12035-015-9213-3. Epub 2015 May 15.
Mol Neurobiol. 2016.
PMID: 25976369
Item in Clipboard
The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia.
Rojo-Bustamante E, Abellanas MA, Clavero P, Thiolat ML, Li Q, Luquin MR, Bezard E, Aymerich MS.
Rojo-Bustamante E, et al.
Neurobiol Dis. 2018 Oct;118:64-75. doi: 10.1016/j.nbd.2018.06.019. Epub 2018 Jun 21.
Neurobiol Dis. 2018.
PMID: 29936234
Item in Clipboard
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
Celorrio M, Fernández-Suárez D, Rojo-Bustamante E, Echeverry-Alzate V, Ramírez MJ, Hillard CJ, López-Moreno JA, Maldonado R, Oyarzábal J, Franco R, Aymerich MS.
Celorrio M, et al. Among authors: rojo bustamante e.
Brain Behav Immun. 2016 Oct;57:94-105. doi: 10.1016/j.bbi.2016.06.010. Epub 2016 Jun 16.
Brain Behav Immun. 2016.
PMID: 27318096
Item in Clipboard
Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.
Elgueta D, Aymerich MS, Contreras F, Montoya A, Celorrio M, Rojo-Bustamante E, Riquelme E, González H, Vásquez M, Franco R, Pacheco R.
Elgueta D, et al. Among authors: rojo bustamante e.
Neuropharmacology. 2017 Feb;113(Pt A):110-123. doi: 10.1016/j.neuropharm.2016.09.028. Epub 2016 Sep 28.
Neuropharmacology. 2017.
PMID: 27693549
Item in Clipboard
GPR55: A therapeutic target for Parkinson's disease?
Celorrio M, Rojo-Bustamante E, Fernández-Suárez D, Sáez E, Estella-Hermoso de Mendoza A, Müller CE, Ramírez MJ, Oyarzábal J, Franco R, Aymerich MS.
Celorrio M, et al. Among authors: rojo bustamante e.
Neuropharmacology. 2017 Oct;125:319-332. doi: 10.1016/j.neuropharm.2017.08.017. Epub 2017 Aug 12.
Neuropharmacology. 2017.
PMID: 28807673
Item in Clipboard
Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants.
Razquin C, Ortega-Cubero S, Rojo-Bustamante E, Diez-Fairen M, Lorenzo E, Alonso E, Ezquerra M, Ross OA, Carcel M, Lorenzo-Betancor O, Soto AI, Burgess JD, Ertekin-Taner N, Dickson DW, Pastor MA, Tolosa E, Pastor P.
Razquin C, et al. Among authors: rojo bustamante e.
Neurobiol Aging. 2018 Jun;66:177.e7-177.e10. doi: 10.1016/j.neurobiolaging.2017.12.026. Epub 2018 Jan 11.
Neurobiol Aging. 2018.
PMID: 29398119
Free PMC article.
Item in Clipboard
Comparative global analysis of stroke rehabilitation recommendations across income levels.
Rodríguez-Orozco JE, Martínez-Rubio CF, Moreno-Vargas E, Peña-Ortiz A, Pizarro-Peñaranda MC, Rojo-Bustamante E, Villarreal-García DE, Bayona-Ortiz HF.
Rodríguez-Orozco JE, et al. Among authors: rojo bustamante e.
J Clin Epidemiol. 2024 Mar 27;170:111334. doi: 10.1016/j.jclinepi.2024.111334. Online ahead of print.
J Clin Epidemiol. 2024.
PMID: 38548231
Item in Clipboard
Cite
Cite